Fitbit tracks sleep to reveal hidden benefits of Crohn's treatments

NCT ID NCT07649408

Recruiting now Knowledge-focused Sponsor: Shmuel Kivity, MD Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study investigates whether advanced treatments for Crohn's disease also improve sleep quality. Adults with active Crohn's who are about to start a new advanced therapy will wear a Fitbit Inspire 3 for five days at three different times: before treatment, at week 4, and at week 8. They will also complete sleep diaries and questionnaires. The goal is to see if better disease control leads to better sleep, which could offer a simple way to monitor treatment success.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Fitbit Inspire 3 wearable tracker
What this could lead to: If sleep improves with treatment, this could point toward using sleep tracking as a simple way to measure how well Crohn's therapy is working.
What could go wrong: This is a small, observational study with only 30 participants, so results may not apply to everyone. Sleep changes could be due to other factors, not just the treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE (CD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Crohn disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CROHN DISEASE (CD)

Contacts and locations

Locations

Dep. of Gastroenterology, Tel Aviv Sourasky Medical Center
RECRUITING

Tel Aviv, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.